Mymetics Corp (MYMX)

[Work Harder]

The platform, which is known as OMNIVAX and is sponsored by the BMGF, aims to reduce the per-dose price of the trivalent poliovirus vaccine from around $2 to $0.15.

More recently, Batavia has been working with Univercells and Merck to create a low-cost manufacturing platform that will significantly ease the cost of global health vaccines.

The company has state-of-the-art laboratory infrastructure in both the Netherlands and the US, and is well equipped to develop any biopharmaceutical – be it an antibody, recombinant protein or vaccine – from early discovery all the way through to clinical manufacturing.

https://www.theneweconomy.com/technology/a-fairy-godmother-for-research-and-development-in-biopharmaceuticals

https://www.bataviabiosciences.com/